166 related articles for article (PubMed ID: 32769096)
1. Metabolic Acidosis and CKD Progression.
Madias NE
Clin J Am Soc Nephrol; 2021 Feb; 16(2):310-312. PubMed ID: 32769096
[No Abstract] [Full Text] [Related]
2. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
[TBL] [Abstract][Full Text] [Related]
3. Low Serum Bicarbonate and CKD Progression in Children.
Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
[TBL] [Abstract][Full Text] [Related]
4. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
[TBL] [Abstract][Full Text] [Related]
5. Current status of bicarbonate in CKD.
Dobre M; Rahman M; Hostetter TH
J Am Soc Nephrol; 2015 Mar; 26(3):515-23. PubMed ID: 25150154
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease - Position Statement of the Working Group of the Polish Society of Nephrology.
Adamczak M; Masajtis-Zagajewska A; Mazanowska O; Madziarska K; Stompór T; Więcek A
Kidney Blood Press Res; 2018; 43(3):959-969. PubMed ID: 29895022
[TBL] [Abstract][Full Text] [Related]
7. Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
Mathur VS; Wesson DE; Tangri N; Li E; Bushinsky DA
BMC Nephrol; 2022 Feb; 23(1):82. PubMed ID: 35216581
[TBL] [Abstract][Full Text] [Related]
8. Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.
Scialla JJ; Asplin J; Dobre M; Chang AR; Lash J; Hsu CY; Kallem RR; Hamm LL; Feldman HI; Chen J; Appel LJ; Anderson CA; Wolf M;
Kidney Int; 2017 Jan; 91(1):204-215. PubMed ID: 27914710
[TBL] [Abstract][Full Text] [Related]
9. Hyperchloremic acidosis develops at the stage G4 and shifts to high anion gap acidosis at the stage G5 in chronic kidney disease.
Tanemoto M; Kamachi R; Kimura T; Yamada S; Yokoyama T; Okazaki Y
Clin Exp Nephrol; 2020 Dec; 24(12):1140-1143. PubMed ID: 32772208
[TBL] [Abstract][Full Text] [Related]
10. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
[TBL] [Abstract][Full Text] [Related]
11. Management of the Metabolic Acidosis of Chronic Kidney Disease.
Goraya N; Wesson DE
Adv Chronic Kidney Dis; 2017 Sep; 24(5):298-304. PubMed ID: 29031356
[TBL] [Abstract][Full Text] [Related]
12. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
[TBL] [Abstract][Full Text] [Related]
13. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
[TBL] [Abstract][Full Text] [Related]
14. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
[TBL] [Abstract][Full Text] [Related]
15. Urine Ammonium, Metabolic Acidosis and Progression of Chronic Kidney Disease.
Pourafshar N; Pourafshar S; Soleimani M
Nephron; 2018; 138(3):222-228. PubMed ID: 29050011
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic acidosis in chronic kidney disease].
Havlín J; Matoušovic K; Vaňková S; Schück O
Vnitr Lek; 2016; 62 Suppl 6():30-39. PubMed ID: 28124929
[TBL] [Abstract][Full Text] [Related]
17. Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?
Kovesdy CP
Nephrol Dial Transplant; 2012 Aug; 27(8):3056-62. PubMed ID: 22851628
[TBL] [Abstract][Full Text] [Related]
18. Oral sodium bicarbonate improves thyroid function in predialysis chronic kidney disease.
Disthabanchong S; Treeruttanawanich A
Am J Nephrol; 2010; 32(6):549-56. PubMed ID: 21042013
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD.
Raphael KL
J Am Soc Nephrol; 2018 Feb; 29(2):376-382. PubMed ID: 29030467
[TBL] [Abstract][Full Text] [Related]
20. Bicarbonate therapy in severe metabolic acidosis.
Sabatini S; Kurtzman NA
J Am Soc Nephrol; 2009 Apr; 20(4):692-5. PubMed ID: 18322160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
